These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 36418402)
1. Structural basis of tankyrase activation by polymerization. Pillay N; Mariotti L; Zaleska M; Inian O; Jessop M; Hibbs S; Desfosses A; Hopkins PCR; Templeton CM; Beuron F; Morris EP; Guettler S Nature; 2022 Dec; 612(7938):162-169. PubMed ID: 36418402 [TBL] [Abstract][Full Text] [Related]
2. Regulation of tankyrase activity by a catalytic domain dimer interface. Fan C; Yarravarapu N; Chen H; Kulak O; Dasari P; Herbert J; Yamaguchi K; Lum L; Zhang X Biochem Biophys Res Commun; 2018 Sep; 503(3):1780-1785. PubMed ID: 30055800 [TBL] [Abstract][Full Text] [Related]
3. Tankyrase Requires SAM Domain-Dependent Polymerization to Support Wnt-β-Catenin Signaling. Mariotti L; Templeton CM; Ranes M; Paracuellos P; Cronin N; Beuron F; Morris E; Guettler S Mol Cell; 2016 Aug; 63(3):498-513. PubMed ID: 27494558 [TBL] [Abstract][Full Text] [Related]
4. Structural insights into SAM domain-mediated tankyrase oligomerization. DaRosa PA; Ovchinnikov S; Xu W; Klevit RE Protein Sci; 2016 Sep; 25(9):1744-52. PubMed ID: 27328430 [TBL] [Abstract][Full Text] [Related]
5. Tankyrase Sterile α Motif Domain Polymerization Is Required for Its Role in Wnt Signaling. Riccio AA; McCauley M; Langelier MF; Pascal JM Structure; 2016 Sep; 24(9):1573-81. PubMed ID: 27499439 [TBL] [Abstract][Full Text] [Related]
6. Fragment-based screening identifies molecules targeting the substrate-binding ankyrin repeat domains of tankyrase. Pollock K; Liu M; Zaleska M; Meniconi M; Pfuhl M; Collins I; Guettler S Sci Rep; 2019 Dec; 9(1):19130. PubMed ID: 31836723 [TBL] [Abstract][Full Text] [Related]
7. Tankyrase polymerization is controlled by its sterile alpha motif and poly(ADP-ribose) polymerase domains. De Rycker M; Price CM Mol Cell Biol; 2004 Nov; 24(22):9802-12. PubMed ID: 15509784 [TBL] [Abstract][Full Text] [Related]
8. Tankyrases as drug targets. Lehtiö L; Chi NW; Krauss S FEBS J; 2013 Aug; 280(15):3576-93. PubMed ID: 23648170 [TBL] [Abstract][Full Text] [Related]
9. Solution NMR assignment of the ARC4 domain of human tankyrase 2. Zaleska M; Pollock K; Collins I; Guettler S; Pfuhl M Biomol NMR Assign; 2019 Apr; 13(1):255-260. PubMed ID: 30847846 [TBL] [Abstract][Full Text] [Related]
10. The zinc-binding motif in tankyrases is required for the structural integrity of the catalytic ADP-ribosyltransferase domain. Sowa ST; Lehtiö L Open Biol; 2022 Mar; 12(3):210365. PubMed ID: 35317661 [TBL] [Abstract][Full Text] [Related]
11. Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding. Mariotti L; Pollock K; Guettler S Br J Pharmacol; 2017 Dec; 174(24):4611-4636. PubMed ID: 28910490 [TBL] [Abstract][Full Text] [Related]
12. Insights of tankyrases: A novel target for drug discovery. Damale MG; Pathan SK; Shinde DB; Patil RH; Arote RB; Sangshetti JN Eur J Med Chem; 2020 Dec; 207():112712. PubMed ID: 32877803 [TBL] [Abstract][Full Text] [Related]
13. Zinc binding catalytic domain of human tankyrase 1. Lehtiö L; Collins R; van den Berg S; Johansson A; Dahlgren LG; Hammarström M; Helleday T; Holmberg-Schiavone L; Karlberg T; Weigelt J J Mol Biol; 2008 May; 379(1):136-45. PubMed ID: 18436240 [TBL] [Abstract][Full Text] [Related]
14. Vertebrate tankyrase domain structure and sterile alpha motif (SAM)-mediated multimerization. De Rycker M; Venkatesan RN; Wei C; Price CM Biochem J; 2003 May; 372(Pt 1):87-96. PubMed ID: 12589701 [TBL] [Abstract][Full Text] [Related]
15. Structural and functional analysis of parameters governing tankyrase-1 interaction with telomeric repeat-binding factor 1 and GDP-mannose 4,6-dehydratase. Eisemann T; Langelier MF; Pascal JM J Biol Chem; 2019 Oct; 294(40):14574-14590. PubMed ID: 31375564 [TBL] [Abstract][Full Text] [Related]
16. Structural basis for tankyrase-RNF146 interaction reveals noncanonical tankyrase-binding motifs. DaRosa PA; Klevit RE; Xu W Protein Sci; 2018 Jun; 27(6):1057-1067. PubMed ID: 29604130 [TBL] [Abstract][Full Text] [Related]
17. Tankyrase-targeted therapeutics: expanding opportunities in the PARP family. Riffell JL; Lord CJ; Ashworth A Nat Rev Drug Discov; 2012 Dec; 11(12):923-36. PubMed ID: 23197039 [TBL] [Abstract][Full Text] [Related]
18. The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the β-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2. Croy HE; Fuller CN; Giannotti J; Robinson P; Foley AVA; Yamulla RJ; Cosgriff S; Greaves BD; von Kleeck RA; An HH; Powers CM; Tran JK; Tocker AM; Jacob KD; Davis BK; Roberts DM J Biol Chem; 2016 Jun; 291(24):12747-12760. PubMed ID: 27068743 [TBL] [Abstract][Full Text] [Related]
19. Novel binding mode of a potent and selective tankyrase inhibitor. Gunaydin H; Gu Y; Huang X PLoS One; 2012; 7(3):e33740. PubMed ID: 22438990 [TBL] [Abstract][Full Text] [Related]
20. Identifying and Validating Tankyrase Binders and Substrates: A Candidate Approach. Pollock K; Ranes M; Collins I; Guettler S Methods Mol Biol; 2017; 1608():445-473. PubMed ID: 28695526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]